“Personally, I think it’s a no-brainer,” said gynecological cancer specialist Dr. Robert Grimshaw on Thursday.
Nova Scotia’s official Opposition and Grimshaw are urging the Houston government to speed up a switch from Pap tests to HPV testing for cervical cancer screening — a transition the province has been planning for more than two years, The Canadian Press reported.
The pressure comes the same week New Brunswick announced it is moving to HPV testing as its primary screening method, leaving Nova Scotia as the last Atlantic Canadian province still relying on the Pap test, CTV News reported. Grimshaw, who is medical director of Nova Scotia Health’s cervical cancer screening program but spoke publicly in a personal capacity, told CBC he is “deeply disappointed” by the delays.
The stakes are concrete. Nova Scotia recorded about 11 cases of cervical cancer per 100,000 women per year in 2022, according to the most recent data from the Canadian Partnership Against Cancer.

Pap test finds abnormal cells; HPV test finds the cause
- The Pap test looks for abnormal cells; the HPV test looks for the cause. Human papillomavirus is associated with the vast majority of cervical cancers, so finding the virus first catches risk earlier.
- A negative HPV test protects longer. A single negative result gives about the same protection as Pap tests every two or three years, Grimshaw told CTV News.
- You may eventually be able to screen at home.
Why the test itself works better
The mechanism of action explains the enthusiasm. A Pap test is a cytology exam: cells scraped from the cervix are inspected under a microscope for precancerous changes. An HPV test instead detects DNA from high-risk viral strains before those changes develop, allowing earlier intervention. Grimshaw described the HPV test to CBC as a “superpower” for detecting abnormal cells compared with a Pap test.
It is also cheaper to run at scale.
New Brunswick moved on Wednesday
Neighbouring New Brunswick announced on Wednesday that it is adopting HPV testing as its primary screening method, with an at-home HPV self-sampling option also being developed, Global News reported.

Chender pointed directly at that contrast. “Why won’t the Houston government?” she said in a news release.
What the province says is holding it up
“We just haven’t been able to get any traction,” Grimshaw said.
The department’s statement to CBC acknowledged Nova Scotia is now one of the last provinces to switch to HPV testing, saying it is “learning from their experiences.”

The numbers behind the push
| Measure | Figure | Source |
|---|---|---|
| N.S. cervical cancer rate (2022) | ~11 per 100,000 women/year | Canadian Partnership Against Cancer |
| Elimination target (Canada, before 2040) | Fewer than 4 per 100,000 | Federal action plan |
| Vaccine reduction in two main cancer-causing HPV types (girls, 2014–18, 14 countries) | 83 per cent | Multicountry research cited by CP |
The elimination context matters. Canada has set a goal of eliminating cervical cancer before 2040.
Where the two sides disagree
The disagreement is not about the science — both the specialist and the department accept HPV testing is the goal — but about pace and readiness. The department, for its part, frames the delay as a systems question of lab capacity and follow-up infrastructure. Grimshaw disputes that the barriers are large, pointing to his existing equipment and a modest startup cost.
Positive HPV result does not mean cervical cancer
People should speak with their provider about their personal screening needs.

Nova Scotia still studying switch to HPV self-sampling
Nova Scotia has not committed to a start date. For Nova Scotians, the practical change — a mailed self-sampling kit instead of a clinic appointment — now depends on a decision the department says it is still studying.
Grimshaw, who points out that nearly every tragic case he’s seen could have been prevented by early testing, put it plainly: “We just haven’t been able to get any traction.”
Nova Scotia, whose name is Latin for “New Scotland,” lies on Canada’s east coast and is one of the country’s two smallest provinces by area, though with a population of over 1 million it is the most populous in Atlantic Canada.
It was the site of Port Royal, founded in 1605 as the capital of Acadia and the first permanent European settlement in what would later become Canada, and in 1848 it became the first British colony to achieve responsible government. The province shares its only land border — the one now crossed by patients and screening programs alike — with New Brunswick, its neighbour to the northwest.
References
- The Canadian Press — Nova Scotia urged to speed up the switch to HPV testing to screen for cervical cancer (Nov. 19, 2026)
- CBC News — Specialist ‘deeply disappointed’ by N.S. delays on cervical cancer screening
- CTV News — Opposition urges Nova Scotia to adopt HPV screening instead of Pap tests
- Global News — New Brunswick adopts HPV testing for cervical cancer, Nova Scotia urged to follow
Consult a qualified health care provider about screening and any symptoms.